Kamphuis, Jeanine

Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression

Goodwin, G. M., Aaronson, S. T., Alvarez, O., Arden, P. C., Baker, A., Bennett, J. C., Bird, C., Blom, R. E., Brennan, C., Brusch, D., et al. (2022) · New England Journal of Medicine

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 1,167

Adverse events in clinical treatments with serotonergic psychedelics and MDMA: a mixed-methods systematic review.

Breeksema, J. J., Kuin, B. W., Kamphuis, J., van den Brink, W., Vermetten, E., & Schoevers, R. A. (2022) · Journal of Psychopharmacology

Psychedelics and Drug StudiesSchizophrenia research and treatment

Cited by 178

Maintenance ketamine treatment for depression: A systematic review of efficacy, safety, and tolerability

Smith-Apeldoorn, S. Y., Veraart, J. K., Spijker, J., Kamphuis, J., & Schoevers, R. A. (2022) · The Lancet Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 169

No disease in the brain of a 115 year old woman

den Dunnen, W. F. A., Brouwer, W. H., Bijlard, E., Kamphuis, J., van Linschoten, K., Eggens-Meijer, E., & Holstege, G. (2008) · Neurobiology of Aging

Dementia and Cognitive Impairment ResearchAging and Gerontology Research

Cited by 81

Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study

Breeksema, J. J., Niemeijer, A., Krediet, E., Karsten, T., Kamphuis, J., Vermetten, E., van den Brink, W., & Schoevers, R. (2024) · Scientific Reports

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 58